31,641 Shares in Masimo Corporation $MASI Acquired by Tudor Investment Corp ET AL

Key Points

• Tudor Investment Corp ET AL bought a new position of 31,641 shares of Masimo in the 3rd quarter, worth about $4.67 million, representing roughly 0.06% of the company at quarter-end.
• Analyst sentiment has weakened with multiple downgrades and a MarketBeat consensus rating of "Reduce" and a consensus price target of $181.17.
• Institutional investors own about 85.96% of Masimo, which has a market cap of roughly $9.58 billion and was trading near its 52-week high (opened at $178.30, 52-week high $179.00).

Tudor Investment Corp ET AL acquired a new position in Masimo Corporation (NASDAQ:MASI - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 31,641 shares of the medical equipment provider's stock, valued at approximately $4,669,000. Tudor Investment Corp ET AL owned 0.06% of Masimo at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Allworth Financial LP boosted its holdings in Masimo by 133.9% in the 3rd quarter. Allworth Financial LP now owns 905 shares of the medical equipment provider's stock worth $134,000 after buying an additional 518 shares during the period. Swiss Life Asset Management Ltd boosted its holdings in Masimo by 78.8% in the 3rd quarter. Swiss Life Asset Management Ltd now owns 2,173 shares of the medical equipment provider's stock worth $321,000 after buying an additional 958 shares during the period. Coldstream Capital Management Inc. boosted its holdings in Masimo by 17.2% in the 3rd quarter. Coldstream Capital Management Inc. now owns 2,668 shares of the medical equipment provider's stock valued at $394,000 after purchasing an additional 391 shares during the period. Danske Bank A S bought a new position in Masimo in the 3rd quarter valued at $59,000. Finally, Advisory Services Network LLC bought a new position in Masimo in the 3rd quarter valued at $46,000. 85.96% of the stock is owned by institutional investors.

Analysts Set New Price Targets

MASI has been the subject of several analyst reports. Piper Sandler downgraded shares of Masimo from an "overweight" rating to a "hold" rating and set a $180.00 price target for the company. in a report on Tuesday, February 17th. Weiss Ratings reissued a "sell (d)" rating on shares of Masimo in a report on Thursday, January 22nd. BTIG Research downgraded shares of Masimo from a "buy" rating to a "neutral" rating in a report on Wednesday, February 18th. Raymond James Financial downgraded shares of Masimo from an "outperform" rating to a "market perform" rating in a report on Friday, March 27th. Finally, Stifel Nicolaus set a $180.00 price target on shares of Masimo in a report on Tuesday, February 17th. Eight investment analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Reduce" and a consensus price target of $181.17.

Masimo Price Performance

Shares of NASDAQ:MASI opened at $178.30 on Thursday. The stock has a market cap of $9.58 billion, a PE ratio of -16.92, a PEG ratio of 1.81 and a beta of 1.20. The company's fifty day moving average is $165.81 and its 200 day moving average is $150.23. Masimo Corporation has a 52 week low of $125.94 and a 52 week high of $179.00. The company has a quick ratio of 1.47, a current ratio of 2.49 and a debt-to-equity ratio of 0.72.

Masimo Profile

Masimo NASDAQ: MASI is a global medical technology company specializing in noninvasive monitoring solutions. The company's flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo's portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.